Drug Chatter -- Tracking biopharma stock chatter

💊 Get Daily Updates on Generic Entry, Litigation, Biosimilars, and More…

Profile for Alnylam Pharmaceuticals, Inc. (ALNY)

« Back to company index

ALNY Chatter Timeline

Stock Ticker for ALNY

Most Active Tweeters for ALNY

UserTweets
@StckPro 10
@newsfilterio 5
@Tickeron 5
@bthefirsttoknow 4
@StockNewsBot2 3

Recent Tweets for ALNY

BinfoTrends @BinfoTrends
RT @mRNAdisrupts: #Regulus Therapeutics Announces Successful Completion of Pre-IND Meeting with #FDA for RGLS8429 - PR Newswire $rgls $alny…
January 25th 2022, 9:01pm
SweepCastApp @SweepCastApp
SweepCast alerted: $ALNY with Unusual Options Activity Alerted on $180 PUT Expiring: 03-18-2022 worth 52K? |? Check… https://t.co/AFVwh81ZpT
January 25th 2022, 11:01am
john_bresnahan @john_bresnahan
RT @ByMadeleineA: $ALNY touts long-term data with vutrisiran, but investors really want to know what's going to happen with Apollo-B study…
January 24th 2022, 4:01pm
ByMadeleineA @ByMadeleineA
$ALNY touts long-term data with vutrisiran, but investors really want to know what's going to happen with Apollo-B… https://t.co/1wNQVpjONE
January 24th 2022, 4:01pm
KateMil39656637 @KateMil39656637
$ALNY~Find active market alerts here in this best trading community.https://t.co/Yh9vzkg7nb
January 24th 2022, 3:01pm
newsfilterio @newsfilterio
Alnylam to Webcast Conference Call Discussing Fourth Quarter and Full Year 2021 Financial Results $ALNY https://t.co/mWHG38bc2I
January 24th 2022, 1:01pm
otcdynamics @otcdynamics
$ALNY Alnylam to Webcast Conference Call Discussing Fourth Quarter and Full Year 2021 Financial Results https://t.co/tiSASNjezg
January 24th 2022, 1:01pm
StckPro @StckPro
$ALNY NEW ARTICLE : Alnylam to Webcast Conference Call Discussing Fourth Quarter and Full Year 2021 Financial Resul… https://t.co/bpG1DLe1dD
January 24th 2022, 1:01pm
StckPro @StckPro
$MRK $ALNY NEW ARTICLE : Analysts Offer Insights on Healthcare Companies: Alnylam Pharma (ALNY) and Merck & Company… https://t.co/BfAMgcQBao
January 24th 2022, 1:01pm
StockNewsBot2 @StockNewsBot2
$ALNY Alnylam to Webcast Conference Call Discussing Fourth Quarter and Full Year 2021 Financial Results https://t.co/Cg1FW8gkMc
January 24th 2022, 1:01pm
stock_titan @stock_titan
$ALNY Alnylam to Webcast Conference Call Discussing Fourth Quarter and Full Year 2021 Financial Results https://t.co/c6DvUfX2IN
January 24th 2022, 1:01pm
bthefirsttoknow @bthefirsttoknow
First out// $ALNY: Alnylam to Webcast Conference Call Discussing Fourth Quarter and Full Year 2021 Financial Results https://t.co/E8xo1P0akm
January 24th 2022, 1:01pm
StckPro @StckPro
$ALNY NEW ARTICLE : BMO Capital Keeps Their Hold Rating on Alnylam Pharma (ALNY) https://t.co/ePUDlSIuyw Get all th… https://t.co/G6YJzJAHUL
January 24th 2022, 12:01pm
StckPro @StckPro
$ALNY NEW ARTICLE : H.C. Wainwright Thinks Alnylam Pharma’s Stock is Going to Recover https://t.co/hqGPTRRNG6 Get a… https://t.co/1PET7AidV2
January 24th 2022, 11:01am
StckPro @StckPro
$ALNY $RVPH NEW ARTICLE : Analysts Are Bullish on Top Healthcare Stocks: Alnylam Pharma (ALNY), Reviva Pharmaceutic… https://t.co/ylANvAiqlU
January 24th 2022, 11:01am
AITRADEIDEAS @AITRADEIDEAS
Alnylam Shares Relatively Quiet As Hearing Dealreporter Recirculates Speculation Of Takeover $ALNY https://t.co/S7tGvRAhPK @benzinga
January 24th 2022, 3:01am
Sarah_Katilyn @Sarah_Katilyn
$ALNY let's switch it up and toss a large capper in the mix shall we https://t.co/smgAc0bBPE
January 23rd 2022, 10:01pm
Tickeron @Tickeron
$ALNY's 10-day Moving Average moved below its 50-day Moving Average on January 3, 2022. View odds for this and othe… https://t.co/32pzD6DB4x
January 23rd 2022, 1:01pm
PenkeTrading @PenkeTrading
I found you a Death Cross on the daily chart of Alnylam Pharmaceuticals Inc. $ALNY $ALNY.NASDAQ #deathcross… https://t.co/wJNM2px5VU
January 23rd 2022, 3:01am
SweepCastApp @SweepCastApp
SweepCast alerted: $ALNY with Unusual Options Activity Alerted on $150 PUT Expiring: 01-21-2022 worth 39K? |? Learn… https://t.co/Dt5aatkVi0
January 23rd 2022, 12:01am
Tickeron @Tickeron
$ALNY's 10-day Moving Average crossed below its 50-day Moving Average on January 3, 2022. View odds for this and ot… https://t.co/kIcIF000Bp
January 22nd 2022, 6:01pm
newsfilterio @newsfilterio
Alnylam: Biotech To Watch With Potential FDA Approval Of Vutrisiran For Rare Disease $ALNY https://t.co/zuF1RWxdPg
January 22nd 2022, 4:01pm
StckPro @StckPro
$ALNY NEW ARTICLE : Alnylam: Biotech To Watch With Potential FDA Approval Of Vutrisiran For Rare Disease… https://t.co/jBxrfEWLse
January 22nd 2022, 4:01pm
SeekingAlpha @SeekingAlpha
$ALNY - Alnylam: Biotech To Watch With Potential FDA Approval Of Vutrisiran For Rare Disease.… https://t.co/nfQOJlsknf
January 22nd 2022, 4:01pm
SharonC22112717 @SharonC22112717
$ALNY *Hey guys, I've made $55K with them in a week, by their alerts ,,_, https://t.co/eSAhmWl4Bw
January 22nd 2022, 4:01am
NEWZHQ @NEWZHQ
RT @OryoJohn: $ALNY: Alnylam Presents Positive 18-Month Results from HELIOS-A Phase 3 Study of Investigational Vutrisiran in Patients with…
January 21st 2022, 10:01pm
MarcJacksonLA @MarcJacksonLA
$ALNY Alnylam touts data replication for next-generation Onpattro in ATTR trial but analysts pour some cold water https://t.co/aT4f0y6rOU
January 21st 2022, 10:01pm
MaisaCorp @MaisaCorp
$ALNY saying vutrisiran, an investigational RNAi therapeutic being developed to treat transthyretin-mediated amyloi… https://t.co/2yTnCGBFbg
January 21st 2022, 10:01pm
bthefirsttoknow @bthefirsttoknow
First out// $ALNY: A Bearish Sign Appears On Alnylam Pharmaceuticals's Chart https://t.co/xzBv7nAxw5
January 21st 2022, 2:01pm
govermentchild @govermentchild
$alny added to my postition
January 21st 2022, 2:01pm
newsfilterio @newsfilterio
Alnylam' Reveals Detailed 18-Month Data From Vutrisiran Trial In Inherited Disease $ALNY https://t.co/p3Aqt3UihL
January 21st 2022, 2:01pm
MarcJacksonLA @MarcJacksonLA
$ALNY Alnylam Presents Positive 18-Month Results from HELIOS-A Phase 3 Study of Investigational Vutrisiran in Patie… https://t.co/DddEtkWakc
January 21st 2022, 2:01pm
Briefingcom @Briefingcom
$ALNY: Alnylam Pharma Presents Positive 18-Month Results from HELIOS-A Phase 3 Study of Investigational Vutrisiran.… https://t.co/1EmtA1kv1Y
January 21st 2022, 2:01pm
MarcJacksonLA @MarcJacksonLA
$ALNY Yvonne Greenstreet Aims to Take Alnylam to the Top 5 by ’25 | BioSpace https://t.co/fB8QqMnZ4L #jobs
January 21st 2022, 2:01pm
GetOnTrade @GetOnTrade
$ALNY Alnylam Highlights 18Month Results From HELIOSA Phase 3 Study Of Vutrisiran All Secondary Endpoints Were Met… https://t.co/XrAH29hi8z
January 21st 2022, 1:01pm
Gambiste1 @Gambiste1
RT @WebChronicleTo1: $ALNY Alnylam Presents Positive 18-Month Results from HELIOS-A Phase 3 Study of Investigational Vutrisiran in Patients…
January 21st 2022, 12:01pm
OryoJohn @OryoJohn
$ALNY: Alnylam Presents Positive 18-Month Results from HELIOS-A Phase 3 Study of Investigational Vutrisiran in Pati… https://t.co/FbBgZdlegs
January 21st 2022, 12:01pm
newsinthemarket @newsinthemarket
Alnylam announces HELIOS-A study meets all secondary endpoints $ALNY
January 21st 2022, 12:01pm
FlashAlert_me @FlashAlert_me
$ALNY [15s. delayed]: Issued Press Release on January 21, 07:30:00: Alnylam Presents Positive 18-Month Results from… https://t.co/41WSpEBoao
January 21st 2022, 12:01pm
StockNewsBot2 @StockNewsBot2
$ALNY Alnylam Presents Positive 18-Month Results from HELIOS-A Phase 3 Study of Investigational Vutrisiran in Patie… https://t.co/qPTBweLgBn
January 21st 2022, 12:01pm
quantisnow @quantisnow
$ALNY ? Alnylam Presents Positive 18-Month Results from HELIOS-A Phase 3 Study of Investigational Vutrisiran in Pat… https://t.co/044JZN18aW
January 21st 2022, 12:01pm
stock_titan @stock_titan
$ALNY Alnylam Presents Positive 18-Month Results from HELIOS-A Phase 3 Study of Investigational Vutrisiran in Patie… https://t.co/268pSPTTE9
January 21st 2022, 12:01pm
WebChronicleTo1 @WebChronicleTo1
$ALNY Alnylam Presents Positive 18-Month Results from HELIOS-A Phase 3 Study of Investigational Vutrisiran in Patie… https://t.co/bfhw1INtMr
January 21st 2022, 12:01pm
GetOnTrade @GetOnTrade
$ALNY HC Wainwright & Co. Maintains Buy on Alnylam Pharmaceuticals, Raises Price Target to $350 https://t.co/xsHMOoHr7d
January 20th 2022, 10:01pm
MC_OptionTrades @MC_OptionTrades
$ALNY 21-Jan-22 Straddle Implies a ±2.7% move. Jan 21 Socit Francophone du Nerf Priphrique Annual Meeting https://t.co/guU4GWiQ50
January 20th 2022, 9:01pm
BenzingaMedia @BenzingaMedia
$ALNY, $ALNY What 10 Analyst Ratings Have To Say About Alnylam Pharmaceuticals - https://t.co/eEtVyjDRQ7
January 20th 2022, 8:01pm
MarketCurrents @MarketCurrents
$ALNY - Alnylam price target raised by 40% at H.C. Wainwright citing upcoming catalysts https://t.co/VPDZW7nepX
January 20th 2022, 7:01pm
Tickeron @Tickeron
$ALNY enters a Downtrend because Momentum Indicator dropped below the 0 level on December 27, 2021. View odds for t… https://t.co/OsohCXoWKu
January 20th 2022, 6:01pm
LargeVoidBot @LargeVoidBot
Daily Reversal (10:22): $ALNY Last: 144.25; pHigh: 144.20; rVol: 1.256; pClose: 138.60; LOD: 142.8100; Perf: 4.1%
January 20th 2022, 3:01pm
GenevaSimon19 @GenevaSimon19
$ALNY *Hey guys, I've made $55K with them in a week, by their alerts ,._, https://t.co/8N0z3lY2LF
January 20th 2022, 2:01pm

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2022. All rights reserved.